机器学习预测颈动脉支架置入术后结局
本研究利用NSQIP血管数据库2011至2021年经股动脉颈动脉支架置入术(CAS)患者2093例,用36项术前变量训练6种机器学习模型预测30天主要不良心血管事件(MACE)。最佳模型XGBoost的AUROC为0.93(95%CI 0.92-0.94),优于逻辑回归的0.67(95%CI 0.65-0.68)。
要点
- XGBoost预测30天MACE的AUROC为0.93(95%CI 0.92-0.94),优于逻辑回归的0.67(95%CI 0.65-0.68)。
- 30天MACE发生130例(6.2%),模型校准良好,Brier评分0.02。
- 最重要的预测特征为症状性颈动脉狭窄、年龄和美国麻醉医师协会分级。
核心结论
- 机器学习模型利用术前数据可准确预测经股动脉CAS术后30天结局,可能有助于指导风险缓解策略以改善结局。
研究设计与样本
- 使用NSQIP靶向血管数据库识别2011至2021年接受经股动脉CAS的患者,输入36项术前人口学/临床变量,数据按70%训练集和30%测试集拆分,采用10折交叉验证训练6种机器学习模型,以逻辑回归为基线 comparator,主要评价指标为AUROC。
主要发现
- 共2093例患者接受CAS,30天MACE发生于130例(6.2%)。
- 预测30天MACE的最佳模型为XGBoost,AUROC(95%CI)为0.93(0.92-0.94);逻辑回归的AUROC(95%CI)为0.67(0.65-0.68);文献中现有工具的AUROC范围为0.58至0.74。
- 对于次要结局,XGBoost的AUROC介于0.86至0.97之间。
- 校准图显示预测事件概率与观察事件概率一致性良好,Brier评分为0.02。
- 算法中排名前三的预测特征为:(1)症状性颈动脉狭窄,(2)年龄,(3)美国麻醉医师协会分级。
临床怎么用
- 作者认为机器学习模型利用术前数据可准确预测经股动脉CAS术后30天结局,可能有助于指导考虑CAS患者的风险缓解策略以改善结局。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Carotid artery stenting (CAS) carries important perioperative risks. Outcome prediction tools may help guide clinical decision-making but remain limited. We developed machine learning (ML) algorithms that predict 30-day outcomes following transfemoral CAS. METHODS: The National Surgical Quality Improvement Program (NSQIP) targeted vascular database was used to identify patients who underwent transfemoral CAS between 2011 and 2021. Input features included 36 preoperative demographic/clinical variables. The primary outcome was a 30-day major adverse cardiovascular event (MACE; composite of stroke, myocardial infarction [MI], or death). The secondary outcomes were 30-day stroke, MI, death, carotid-related morbidity, other morbidity, non-home discharge, and unplanned readmission. Our data were split into training (70%) and test (30%) sets. Using 10-fold cross-validation, we trained six ML models using preoperative features with logistic regression as the baseline comparator. The primary model evaluation metric was area under the receiver operating characteristic curve (AUROC). Model robustness was evaluated with calibration plot and Brier score. Variable importance scores were calculated to determine the top 10 predictive features. Performance was assessed on subgroups based on age, sex, race, ethnicity, symptom status, stent type, and urgency. RESULTS: Overall, 2093 patients underwent CAS during the study period. Thirty-day MACE occurred in 130 (6.2%) patients. The best-performing prediction model for 30-day MACE was XGBoost, achieving an AUROC (95% CI) of 0.93 (0.92-0.94). In comparison, logistic regression had an AUROC (95% CI) of 0.67 (0.65-0.68), and existing tools in the literature demonstrate AUROCs ranging from 0.58 to 0.74. For secondary outcomes, XGBoost achieved AUROCs between 0.86 and 0.97. The calibration plot showed good agreement between predicted and observed event probabilities with a Brier score of 0.02. The top three predictive features in our algorithm were (1) symptomatic carotid stenosis, (2) age, and (3) American Society of Anesthesiologists classification. Model performance remained robust on all subgroup analyses of specific demographic and clinical populations. CONCLUSIONS: Our ML models accurately predict 30-day outcomes following transfemoral CAS using preoperative data. They have the potential for important utility in guiding risk-mitigation strategies for patients being considered for CAS to improve outcomes.Clinical ImpactTransfemoral carotid artery stenting (CAS) carries important perioperative risks. Outcome prediction tools may help guide clinical decision-making but remain limited. Using data from the National Surgical Quality Improvement Program (NSQIP) targeted vascular database, we developed machine learning (ML) models that accurately predict 30-day outcomes following transfemoral CAS using preoperative data, outperforming logistic regression and existing tools in the literature. The models were well-calibrated and remained robust across demographic and clinical subpopulations. These ML algorithms have the potential for important utility in guiding risk-mitigation strategies for patients being considered for transfemoral CAS to improve outcomes.
引用
- Li B, Aljabri B, Beaton D, et al. Predicting Outcomes Following Carotid Artery Stenting Using Machine Learning. J Endovasc Ther. 2025. PMID: 40249213. doi:10.1177/15266028251333670
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。